Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Pfizer’s Covid Boost Crashes to Earth
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
Tornado Damages Key Pfizer Drugmaking Plant
The plant in Rocky Mount, N.C., produces a quarter of the sterile injectable medicines used by U.S. hospitals. Source link
Morgan Stanley Maintains Pfizer (PFE) Equal-Weight Recommendation
Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Pfizer (NYSE:PFE) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 24.43% Upside As
Health Care Sector Update for 04/10/2023: PFE, VRTX, CANF, PHG
Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV)
Guru Fundamental Report for PFE
Below is Validea’s guru fundamental report for PFIZER INC. (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Earnings Yield Investor
PFE vs. ABBV: Which Pharmaceutical Stock is Better?
In this piece, I used TipRanks’ comparison tool to evaluate two pharmaceutical stocks, Pfizer Inc. (NYSE:PFE) and AbbVie Inc. (NYSE:ABBV), to determine which is better.
Noteworthy Tuesday Option Activity: PFE, GLPI, NVCR
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Pfizer Inc (Symbol: PFE), where a total
Bear of the Day: Pfizer Inc. (PFE)
The Zacks Medical sector has struggled in 2023, down roughly 5% YTD and underperforming relative to the S&P 500. One stock residing in the realm,
